{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome uvéo-méningo-encéphalique : Questions médicales les plus fréquentes",
"headline": "Syndrome uvéo-méningo-encéphalique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome uvéo-méningo-encéphalique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D020274",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D020274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique",
"alternateName": "Uveomeningoencephalitic Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D014607",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Leen Alblaihed",
"url": "https://questionsmedicales.fr/author/Leen%20Alblaihed",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed."
}
},
{
"@type": "Person",
"name": "Maite Anna Huis In 't Veld",
"url": "https://questionsmedicales.fr/author/Maite%20Anna%20Huis%20In%20%27t%20Veld",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl."
}
},
{
"@type": "Person",
"name": "Yehuda Shoenfeld",
"url": "https://questionsmedicales.fr/author/Yehuda%20Shoenfeld",
"affiliation": {
"@type": "Organization",
"name": "Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Ramat-Gan; Reichmann University, Herzliya, Israel."
}
},
{
"@type": "Person",
"name": "Rosanna Fulchiero",
"url": "https://questionsmedicales.fr/author/Rosanna%20Fulchiero",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA."
}
},
{
"@type": "Person",
"name": "Patricia Seo-Mayer",
"url": "https://questionsmedicales.fr/author/Patricia%20Seo-Mayer",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Performance of the SARC-F in identifying low grip strength and physical performance in older adults with cancer.",
"datePublished": "2023-01-17",
"url": "https://questionsmedicales.fr/article/36657248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgo.2022.101424"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of a multicomponent programme based on reality orientation therapy on the physical performance and cognitive function of elderly community-dwellers: a quasi-experimental study.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37474259",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/psyg.13008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Plyometric Training Direction on Physical Performance in Basketball Players.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36889323",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1123/ijspp.2022-0239"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Age on Physical Match Performance in Professional Soccer Players.",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/31268996",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1519/JSC.0000000000003244"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Stroop task duration on subsequent cognitive and physical performance.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37665903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychsport.2023.102459"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies auto-immunes du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D020274"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome uvéo-méningo-encéphalique",
"item": "https://questionsmedicales.fr/mesh/D014607"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome uvéo-méningo-encéphalique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome uvéo-méningo-encéphalique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres maladies ?\nQuelle est l'importance de l'analyse du LCR ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Physical+Functional+Performance&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les symptômes principaux du syndrome ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir de la fièvre avec ce syndrome ?\nLes symptômes sont-ils toujours présents ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Physical+Functional+Performance&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?\nLes vaccinations sont-elles efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nY a-t-il des groupes à risque ?\nLes voyages augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Physical+Functional+Performance&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome uvéo-méningo-encéphalique",
"description": "Quel est le traitement principal du syndrome ?\nLes antibiotiques sont-ils nécessaires ?\nComment gérer les symptômes neurologiques ?\nY a-t-il des traitements préventifs ?\nQuelle est la durée du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Physical+Functional+Performance&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome uvéo-méningo-encéphalique",
"description": "Quelles sont les complications possibles ?\nLe syndrome peut-il entraîner des séquelles à long terme ?\nY a-t-il un risque de récidive ?\nComment surveiller les complications ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Physical+Functional+Performance&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'environnement peut-il affecter le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Physical+Functional+Performance&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie cérébrale et des analyses de liquide céphalorachidien."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des IRM, des tomodensitométries et des analyses de sang et de LCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête, des troubles visuels et des convulsions peuvent indiquer le syndrome."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres infections neurologiques comme la méningite bactérienne."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'analyse du LCR ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du LCR permet de détecter des signes d'inflammation et d'infection, cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des troubles de la vision, et des signes neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des convulsions, des troubles de la conscience et des déficits neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on avoir de la fièvre avec ce syndrome ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre est un symptôme fréquent, souvent accompagnée de signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent présenter des symptômes légers ou intermittents."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la vaccination contre les infections virales et l'hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections virales associées au syndrome."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont recommandés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées et celles vivant dans des zones d'épidémie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où des infections virales sont endémiques peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut des antiviraux, des corticostéroïdes et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne sont pas efficaces contre les infections virales, mais peuvent être utilisés si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes neurologiques peuvent être gérés par des anticonvulsivants et des soins neurologiques spécialisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour ce syndrome."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité de l'infection et la réponse au traitement, souvent plusieurs semaines."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des séquelles neurologiques, des troubles de la vision et des crises épileptiques."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des séquelles neurologiques à long terme après le traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de récidive dépend de la cause sous-jacente et de l'état immunitaire du patient."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des examens neurologiques et des imageries est essentiel pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié de l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, les infections virales antérieures et l'exposition à des vecteurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont souvent plus à risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections neurologiques augmentent le risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "L'environnement peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque."
}
}
]
}
]
}
Remote, online geriatric assessment (GA) is gaining attention in oncology. Most GA domains can be assessed remotely. However, there is limited evidence identifying reliable tools that can be used in l...
Data were prospectively collected from older adults with cancer of any type and stage who underwent GA in the geriatric oncology clinic of a tertiary cancer centre. Following GA, patients were asked t...
Eighty (n = 80) older adults (mean age: 80 years) with cancer completed the SARC-F. A positive SARC-F was found in 31.3% of the cohort. Moderate correlations were found between the SPPB per point and ...
SARC-F exhibited promising performance in identifying low grip strength per FNIH and low SPPB combined. To definitively assess the performance of the SARC-F in detecting low grip strength and SPPB, la...
Effects of a multicomponent exercise programme have an impact on the physical, cognitive, and psychological domains in elderly community-dwellers. However, some individuals aged 65 years or more have ...
Participants were recruited from the general public in 20 areas of Akita Prefecture, Japan, and they took part in each exercise programme for 90 min a day, once every 2 weeks, for 3 months, according ...
The final samples for analysis consisted of 31 participants in the control group and 30 participants in the intervention group. The results of the statistical analysis comparing the two groups showed ...
The results of our quasi-experimental study indicated that the multicomponent programme based on the ROT would be as effective as the original multicomponent programme combined with aerobic exercise a...
The aim of this study was to analyze the effects of plyometric training direction on jumping, sprinting, and change-of-direction ability in basketball players....
Forty male basketball players (21.8 [3.8] y), from 4 teams that competed in regional and national championships, were randomly assigned to 1 of 4 groups: (1) vertical jump group, (2) horizontal jump g...
The vertical and horizontal jump group showed significant increases in all performance variables examined, except for linear sprint performance, in which no group improved. The vertical jump group sho...
These results indicate that combining vertical and horizontal jumps induces improvements in more capabilities than does training only vertical or horizontal jumps with the same training volume. Traini...
Rey, E, Costa, PB, Corredoira, FJ, and Sal de Rellán Guerra, A. Effects of age on physical match performance in professional soccer players. J Strength Cond Res 37(6): 1244-1249, 2023-This study aimed...
The strength model of self-control purports to explain why brief cognitive response inhibition tasks impair subsequent isometric handgrip endurance. According to the model, ego depleting tasks requiri...
Validated tools to evaluate physical performance remotely with real-time supervision are lacking. We assessed test−retest and inter-rater reliability, as well as the feasibility of carrying out the fi...
To compare the effects of variable-resistance complex training (VRCT) versus traditional complex training (TCT) on strength, power, speed, and leg stiffness (Kleg) in rugby league players during a 6-w...
Twenty-four rugby league players competing in the British University and Colleges Sport Premier North Division were randomized to VRCT (n = 8), TCT (n = 8), or control (CON; n = 8). Experimental group...
VRCT and TCT significantly improved 1RM back squat, countermovement jump peak power, and 5-m sprint time (all P < .05). VRCT also improved Kleg, whereas TCT improved 10- and 20-m sprint times (all P <...
VRCT and TCT can be implemented during the competitive season to improve strength, power, and 5-m sprint time. VRCT may lead to greater improvements in reactive strength index and Kleg, whereas TCT ma...
Maintaining the physical performance of cancer patients is increasingly considered due to the growing number of cancer patients and the aggressiveness of the treatments. For this reason, bioimpedance ...
Levothyroxine is commonly used to treat hypothyroidism. This study investigates how far the intake of L-T4 influences body composition, energy expenditure, respiratory quotient as well as strength, en...
This study aimed to carry out a systematic review to analyze, describe and discuss the effect of physical fatigue on the performance of soccer players. For this systematic review, searches were perfor...